{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-002107","form_type":"8-K","ticker":"DXR","cik":"0000027367","company_name":"DAXOR CORP","filed_at":"2022-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.175285+00:00","generated_at":"2026-06-27T16:20:08.203655+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Daxor appoints Caleb DesRosiers to Board of Directors","bullets":["Caleb DesRosiers, JD, MPA, appointed to Board effective January 18, 2022, until next annual meeting.","Currently senior principal at Valuate Healthcare (part of Omnicom); previously Chief Strategy Officer at PrescribeWellness.","Board determined Mr. DesRosiers meets NYSE independence standards and qualifies under Regulation S-K Item 407(a).","He has no beneficial ownership of Daxor stock or rights to acquire stock as of appointment date.","Will receive standard non-employee director compensation as described in the company's proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-002107","json":"https://secwatch.observer/filing/0001493152-22-002107.json","markdown":"https://secwatch.observer/filing/0001493152-22-002107.md","text":"https://secwatch.observer/filing/0001493152-22-002107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/27367/000149315222002107/0001493152-22-002107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/27367/000149315222002107/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:20:08.203655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19f6bf95a8","claim":"Caleb DesRosiers was appointed as Director at DAXOR CORP.","evidence_excerpt":"On January 18, 2022, Caleb DesRosiers, JD, MPA was appointed to the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/27367/000149315222002107/0001493152-22-002107-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}